Beyond their established role in the treatment of T2DM and obesity, GLP-1 RAs are increasingly being investigated for their therapeutic potential in a broad spectrum of metabolic diseases due to their pleiotropic actions, which affect glucose and lipid regulation, inflammation, and organ function
Dosing and Administration# GHRP-6 Dosing# Typical research dose : 100-300 mcg per administration, subcutaneous Frequency : 2-3 times daily Timing : Best administered on an empty stomach
These results support continued development, but they do not establish long-term safety, maintenance after discontinuation or cardiovascular benefit
That being said, there is no single best weight loss medication thats right for everyone
M.MoererO.HilgersR.HerrmannP.et al (2008)
In North America, 3040% of patients with mCRPC do not respond to initial docetaxel treatment, and in Asia, up to 45% of patients may not benefit from docetaxel-based therapy (27)